Radiation dosimetry of [18F]VAT in nonhuman primates
Open Access
- 10 December 2015
- journal article
- research article
- Published by Springer Nature in EJNMMI Research
- Vol. 5 (1) , 1-6
Abstract
The objective of this study is to determine the radiation dosimetry of a novel radiotracer for vesicular acetylcholine transporter (−)-(1-((2R,3R)-8-(2-[18F]fluoro-ethoxy)-3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)piperidin-4-yl)(4-fluorophenyl)-methanone ([18F]VAT) based on PET imaging in nonhuman primates. [18F]VAT has potential for investigation of neurological disorders including Alzheimer’s disease, Parkinson’s disease, and dystonia. Three macaque fascicularis (two males, one female) received 185.4–198.3 MBq [18F]VAT prior to whole-body imaging in a MicroPET-F220 scanner. Time activity curves (TACs) were created from regions of interest (ROIs) that encompassed the entire small organs or samples with the highest activity within large organs. Organ residence times were calculated based on the TACs. We then used OLINDA/EXM 1.1 to calculate human radiation dose estimates based on scaled organ residence times. Measurements from directly sampled arterial blood yielded a residence time of 0.30 h in agreement with the residence time of 0.39 h calculated from a PET-generated time activity curve measured in the left ventricle. Organ dosimetry revealed the liver as the critical organ (51.1 and 65.4 μGy/MBq) and an effective dose of 16 and 19 μSv/MBq for male and female, respectively. The macaque biodistribution data showed high retention of [18F]VAT in the liver consistent with hepatobiliary clearance. These dosimetry data support that relatively safe doses of [18F]VAT can be administered to obtain imaging in humans.Keywords
Funding Information
- National Institutes of Health (NS075321, MH092797)
- National Institutes of Health (NS061025)
- National Institute of Biomedical Imaging and Bioengineering (MH092797)
This publication has 22 references indexed in Scilit:
- Nicotinicα4β2acetylcholine receptors and cognitive function in Parkinson's diseaseActa Neurologica Scandinavica, 2014
- Selective expression of α‐synuclein‐immunoreactivity in vesicular acetylcholine transporter‐immunoreactive axons in the guinea pig rectum and human colonJournal of Comparative Neurology, 2012
- Synthesis and in Vitro and in Vivo Evaluation of18F-Labeled Positron Emission Tomography (PET) Ligands for Imaging the Vesicular Acetylcholine TransporterJournal of Medicinal Chemistry, 2009
- Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primatesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Fluorine-18-Labeled Benzamide Analogues for Imaging the σ2Receptor Status of Solid Tumors with Positron Emission TomographyJournal of Medicinal Chemistry, 2007
- OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine.2005
- Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging.2005
- Radiation dosimetry of [18F](N-methyl)benperidol as determined by whole-body PET imaging of primatesNuclear Medicine and Biology, 1997
- Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in HaematologyBritish Journal of Haematology, 1995
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEThe Lancet, 1976